ATE277072T1 - Sapogenin derivate zur behandlung von kognitiven störungen - Google Patents
Sapogenin derivate zur behandlung von kognitiven störungenInfo
- Publication number
- ATE277072T1 ATE277072T1 AT00964447T AT00964447T ATE277072T1 AT E277072 T1 ATE277072 T1 AT E277072T1 AT 00964447 T AT00964447 T AT 00964447T AT 00964447 T AT00964447 T AT 00964447T AT E277072 T1 ATE277072 T1 AT E277072T1
- Authority
- AT
- Austria
- Prior art keywords
- treatment
- cognitive disorders
- sapogenin derivatives
- sapogenin
- derivatives
- Prior art date
Links
- 208000010877 cognitive disease Diseases 0.000 title abstract 2
- WQLVFSAGQJTQCK-UHFFFAOYSA-N diosgenin Natural products CC1C(C2(CCC3C4(C)CCC(O)CC4=CCC3C2C2)C)C2OC11CCC(C)CO1 WQLVFSAGQJTQCK-UHFFFAOYSA-N 0.000 title 1
- NWMIYTWHUDFRPL-UHFFFAOYSA-N sapogenin Natural products COC(=O)C1(CO)C(O)CCC2(C)C1CCC3(C)C2CC=C4C5C(C)(O)C(C)CCC5(CCC34C)C(=O)O NWMIYTWHUDFRPL-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9923077.3A GB9923077D0 (en) | 1999-09-29 | 1999-09-29 | Sapogenin derivatives and their use |
| PCT/GB2000/003745 WO2001023407A1 (en) | 1999-09-29 | 2000-09-29 | Sapogenin derivatives and their use in the treatment of cognitive dysfunction |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE277072T1 true ATE277072T1 (de) | 2004-10-15 |
Family
ID=10861838
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00964447T ATE277072T1 (de) | 1999-09-29 | 2000-09-29 | Sapogenin derivate zur behandlung von kognitiven störungen |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US20020183294A1 (de) |
| EP (2) | EP1548025A3 (de) |
| JP (1) | JP2003510333A (de) |
| CN (2) | CN1377367A (de) |
| AT (1) | ATE277072T1 (de) |
| AU (1) | AU7538200A (de) |
| BR (1) | BR0014355A (de) |
| CA (1) | CA2385410C (de) |
| DE (1) | DE60014136T2 (de) |
| ES (1) | ES2228608T3 (de) |
| GB (1) | GB9923077D0 (de) |
| HK (1) | HK1045526B (de) |
| MX (1) | MXPA02003306A (de) |
| WO (1) | WO2001023407A1 (de) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9923076D0 (en) | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
| GB9923078D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
| GB0000228D0 (en) * | 2000-01-06 | 2000-03-01 | Phytopharm Plc | Fluoro substituted sapogenins and their use |
| NZ563183A (en) * | 2002-03-27 | 2009-03-31 | Phytopharm Plc | Therapeutic methods and uses of sapogenins and their derivatives |
| BR0308788A (pt) * | 2002-03-27 | 2005-01-11 | Phytopharm Plc | Processos terapêuticos e usos de sapogeninas e seus derivados |
| PL213697B1 (pl) * | 2002-03-27 | 2013-04-30 | Phytopharm Plc | Substancje czynne do stosowania w leczeniu chorób, zwlaszcza chorób neurodegeneracyjnych |
| US20080182801A1 (en) | 2003-12-22 | 2008-07-31 | Btg International Limited | Core 2 glcnac-t inhibitors |
| GB0329667D0 (en) * | 2003-12-22 | 2004-01-28 | King S College London | Core 2 GlcNAc-T inhibitor |
| GB0513881D0 (en) * | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors III |
| GB0409567D0 (en) | 2004-04-28 | 2004-06-02 | Phytopharm Plc | Chemical compounds |
| GB0512726D0 (en) * | 2005-06-22 | 2005-07-27 | Btg Int Ltd | Multiple sclerosis therapy and diagnosis |
| GB0513888D0 (en) * | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Core 2 GLCNAC-T Inhibitors II |
| GB0513883D0 (en) * | 2005-07-06 | 2005-08-10 | Btg Int Ltd | Diagnosis of Atherosclerosis |
| CN101610673A (zh) * | 2006-11-20 | 2009-12-23 | 萨托里医药公司 | 可用于治疗神经变性紊乱的化合物 |
| CA2670284C (en) | 2006-11-20 | 2013-03-26 | Satori Pharmaceuticals, Inc. | Synthesis of compounds useful as modulators of amyloid-beta production |
| AU2010207597A1 (en) | 2009-01-24 | 2011-08-18 | Phytopharm Plc | Treatment of neurotrophic factor mediated disorders |
| BRPI1009871A2 (pt) * | 2009-03-27 | 2016-03-08 | Moleac Pte Ltd | terapia para promover o crescimento celular |
| BR112013001422A2 (pt) | 2010-07-20 | 2019-09-24 | Phytopharm Plc | metodo para tratar ou previnir disturbios induzidos por l-dopa, agonista dopamina e/ou acentuador de dopamina em um individuo que necessita dos mesmos, agente, composição, uso de ou mais agentes e metodo para tratar a doença de parkinson |
| CU20110244A7 (es) * | 2011-12-27 | 2013-08-29 | Ct De Investigación Y Desarrollo De Medicamentos Cidem | Sistemas espiroesteroidales con efectos neuroactivos y anti-inflamatorios |
| US11319338B2 (en) * | 2012-04-03 | 2022-05-03 | Goldporp Pharma Limited | Timosaponin compounds |
| CN102924559B (zh) * | 2012-11-16 | 2015-10-28 | 沈阳药科大学 | 菝葜皂苷元衍生物及其制备和应用 |
| CN108264535A (zh) | 2016-12-30 | 2018-07-10 | 中国科学院上海药物研究所 | 一种抗抑郁化合物及其制备方法和应用 |
Family Cites Families (48)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2299758A (en) * | 1940-08-03 | 1942-10-27 | Parke Davis & Co | Sapogenin derivative and preparation of the same |
| BE794362A (fr) * | 1972-01-22 | 1973-07-23 | Merck Patent Gmbh | Sulfates hydrosolubles de sterine |
| US3929769A (en) * | 1972-05-19 | 1975-12-30 | Ciba Geigy Corp | Process for the manufacture of steroid epoxides |
| CA985172A (en) * | 1972-10-06 | 1976-03-09 | Dushan M. Dvornik | Compositions and methods for reducing blood cholesterol |
| DE2416978A1 (de) * | 1974-04-08 | 1975-10-09 | Degussa | Arzneimittel mit dem hauptsapogenin der helleborus-arten als wirkstoff |
| LU81256A1 (fr) * | 1979-05-15 | 1980-12-16 | Oreal | Composition cosmetique capillaire notamment pour le lavage et/ou le demelage des cheveux,a base d'un extrait de plantes contenant des saponosides |
| JPS5855500A (ja) * | 1981-09-25 | 1983-04-01 | Tokiwa Yakuhin Kogyo Kk | 16−デヒドロプレグネノロンの製造法 |
| US4602005A (en) * | 1982-05-17 | 1986-07-22 | Medical Research Foundation Of Oregon | Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis |
| US4602003A (en) * | 1982-05-17 | 1986-07-22 | Medical Research Foundation Of Oregon | Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia |
| US4562250A (en) * | 1982-09-13 | 1985-12-31 | Regents Of The University Of Minnesota | Steroidal glycosides produced by Yucca tissue culture |
| US4546097A (en) * | 1983-11-04 | 1985-10-08 | The United States Of America As Represented By The Department Of Health And Human Services | Saponin-based polyether polyols, pharmaceutical compositions and a method of using same |
| US4680289A (en) * | 1985-06-05 | 1987-07-14 | Progenics, Inc. | Treatment of obesity and diabetes using sapogenins |
| US5017562A (en) * | 1987-02-11 | 1991-05-21 | Regents Of The University Of Minnesota | Crystalline saponin-containing complex |
| DE3838716A1 (de) * | 1988-11-15 | 1990-05-17 | Kanoldt Arzneimittel Gmbh | Arzneimittelzubereitung aus esterderivaten des hecogenins und dessen verwendung zur behandlung von benigner prostatahyperplasie |
| ATE188036T1 (de) * | 1990-01-18 | 2000-01-15 | Cura Nominees Pty Ltd | Glykoalkaloide |
| US5252729A (en) * | 1991-10-23 | 1993-10-12 | Schering Corporation | Extraction of compounds from plant materials using supercritical fluids |
| US5244887A (en) * | 1992-02-14 | 1993-09-14 | Straub Carl D | Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof |
| JPH05246866A (ja) * | 1992-03-06 | 1993-09-24 | Ruibosuteii Japan:Kk | 脳代謝促進・脳機能改善剤 |
| BR9306619A (pt) * | 1992-06-26 | 1998-12-08 | Pfizer | Glicosídeos esteroidais para o tratamento da hipercolesterolemia |
| DE4303214A1 (de) * | 1993-02-04 | 1994-08-11 | Wolfgang Marks | Behandlung von Erkrankungen viraler, viroidaler oder onkogener Genese durch Steroid-Saponine oder deren Aglykone |
| WO1994025479A1 (en) * | 1993-04-28 | 1994-11-10 | Pfizer Inc. | Spirostanyl glycosidal crystalline monohydrate |
| CN1033754C (zh) * | 1993-05-31 | 1997-01-08 | 上海第二医科大学 | 知母皂甙元作为制备β肾上腺素和M胆碱受体双向调节药的用途及其制法 |
| US5589182A (en) * | 1993-12-06 | 1996-12-31 | Tashiro; Renki | Compositions and method of treating cardio-, cerebro-vascular and alzheimer's diseases and depression |
| CA2180148A1 (en) * | 1993-12-28 | 1995-07-06 | Michael Paul Deninno | Hypocholesterolemic agents |
| CA2180149A1 (en) * | 1993-12-28 | 1995-07-06 | Michael Paul Deninno | Steroidal glycosides |
| US5856535A (en) * | 1994-08-18 | 1999-01-05 | Magainin Pharmaceuticals, Inc. | Aminosterol ester compounds |
| US5840740A (en) * | 1995-06-07 | 1998-11-24 | Magainin Pharmaceuticals Inc. | Aminosterol compounds and a method of treating infection using the aminosterol compounds |
| PL318937A1 (en) * | 1994-08-30 | 1997-07-21 | Pfizer | Spirostanyloglycoside crystals |
| US5807834A (en) * | 1994-09-20 | 1998-09-15 | Pfizer Inc. | Combination of a cholesterol absorption inhibitor and a cholesterol synthesis inhibitor |
| WO1996038466A1 (en) * | 1995-05-29 | 1996-12-05 | Pfizer Inc. | Steroidal glycosides |
| US5763430A (en) * | 1995-06-07 | 1998-06-09 | Magainin Pharmaceuticals Inc. | Method of treating a viral infection by administering a steroid compound |
| US5795885A (en) * | 1995-06-07 | 1998-08-18 | Magainin Pharmaceuticals Inc. | Method of inhibiting profileration of cells by administering an aminosterol compound |
| US5792635A (en) * | 1995-06-07 | 1998-08-11 | Magainin Pharmaceuticals, Inc. | Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine |
| US6143738A (en) * | 1995-06-07 | 2000-11-07 | Magainin Pharmaceuticals, Inc. | Therapeutic uses for an aminosterol compound |
| US5840936A (en) * | 1995-06-07 | 1998-11-24 | Magainin Pharmaceuticals Inc. | Aminosterol compounds useful as inhibitors of the sodium/proton exchanger (NHE) |
| US5847172A (en) * | 1995-06-07 | 1998-12-08 | Magainin Pharmaceuticals Inc. | Certain aminosterol compounds and pharmaceutical compositions including these compounds |
| ATE205490T1 (de) * | 1995-10-13 | 2001-09-15 | Banyu Pharma Co Ltd | Substituierte heteroaromatische derivate |
| US5726179A (en) * | 1996-04-01 | 1998-03-10 | The University Of Toledo | Muscarinic agonists |
| CN1245982C (zh) * | 1996-05-09 | 2006-03-22 | 阿姆瑞德手术有限公司 | 哮喘和气道疾病的治疗 |
| US5804239A (en) * | 1996-07-26 | 1998-09-08 | Nouveau Technologies, Inc. | Method and composition for food flavoring |
| CN1131237C (zh) * | 1997-09-26 | 2003-12-17 | 中国人民解放军军事医学科学院放射医学研究所 | 甾体皂甙防治老年性痴呆的用途及新的甾体皂甙 |
| JP3873097B2 (ja) * | 1997-11-06 | 2007-01-24 | 独立行政法人理化学研究所 | 抗肥満剤及び脂質代謝改善剤 |
| GB9905275D0 (en) * | 1999-03-08 | 1999-04-28 | Phytopharm Ltd | Treatment of conditions associated with membrane-bound receptors and their function |
| ATE337788T1 (de) * | 1998-03-26 | 2006-09-15 | Phytopharm Plc | Steroidale saponine zur behandlung der alzheimerischen krankheit |
| GB2347676A (en) * | 1999-03-08 | 2000-09-13 | Phytopharm Plc | Screening method |
| US6544566B1 (en) * | 1999-04-23 | 2003-04-08 | Protein Technologies International, Inc. | Composition containing plant sterol, soy protein and isoflavone for reducing LDL cholesterol |
| BR0001794A (pt) * | 2000-05-15 | 2001-12-26 | Laboratorios Biosintetica Ltda | Aplicação de fitosteróides (e seus isÈmeros), ácidofólico, cianocobalamina e piridoxina em fibrasdietéticas (alimentares) |
| US20050130948A1 (en) * | 2002-03-27 | 2005-06-16 | Daryl Rees | Therapeutic methods and uses of sapogenins and their derivatives |
-
1999
- 1999-09-29 GB GBGB9923077.3A patent/GB9923077D0/en not_active Ceased
-
2000
- 2000-09-29 MX MXPA02003306A patent/MXPA02003306A/es active IP Right Grant
- 2000-09-29 BR BR0014355-3A patent/BR0014355A/pt not_active Application Discontinuation
- 2000-09-29 ES ES00964447T patent/ES2228608T3/es not_active Expired - Lifetime
- 2000-09-29 EP EP04021601A patent/EP1548025A3/de not_active Withdrawn
- 2000-09-29 EP EP00964447A patent/EP1224206B1/de not_active Expired - Lifetime
- 2000-09-29 CN CN00813605A patent/CN1377367A/zh active Pending
- 2000-09-29 AU AU75382/00A patent/AU7538200A/en not_active Abandoned
- 2000-09-29 CA CA002385410A patent/CA2385410C/en not_active Expired - Fee Related
- 2000-09-29 DE DE60014136T patent/DE60014136T2/de not_active Expired - Fee Related
- 2000-09-29 WO PCT/GB2000/003745 patent/WO2001023407A1/en not_active Ceased
- 2000-09-29 AT AT00964447T patent/ATE277072T1/de not_active IP Right Cessation
- 2000-09-29 CN CNA2007101294727A patent/CN101143147A/zh active Pending
- 2000-09-29 JP JP2001526557A patent/JP2003510333A/ja active Pending
- 2000-09-29 HK HK02106663.1A patent/HK1045526B/en not_active IP Right Cessation
-
2002
- 2002-03-28 US US10/109,204 patent/US20020183294A1/en not_active Abandoned
-
2007
- 2007-08-20 US US11/894,120 patent/US20080021004A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1548025A2 (de) | 2005-06-29 |
| AU7538200A (en) | 2001-04-30 |
| WO2001023407A1 (en) | 2001-04-05 |
| ES2228608T3 (es) | 2005-04-16 |
| CN1377367A (zh) | 2002-10-30 |
| CN101143147A (zh) | 2008-03-19 |
| US20020183294A1 (en) | 2002-12-05 |
| HK1045526B (en) | 2005-04-22 |
| HK1045526A1 (en) | 2002-11-29 |
| DE60014136D1 (de) | 2004-10-28 |
| US20080021004A1 (en) | 2008-01-24 |
| MXPA02003306A (es) | 2002-10-04 |
| CA2385410A1 (en) | 2001-04-05 |
| JP2003510333A (ja) | 2003-03-18 |
| EP1224206B1 (de) | 2004-09-22 |
| GB9923077D0 (en) | 1999-12-01 |
| DE60014136T2 (de) | 2005-10-06 |
| BR0014355A (pt) | 2002-07-16 |
| EP1548025A3 (de) | 2008-11-19 |
| CA2385410C (en) | 2008-05-20 |
| EP1224206A1 (de) | 2002-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60014136D1 (de) | Sapogenin derivate zur behandlung von kognitiven störungen | |
| DK1578740T3 (da) | 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet | |
| DK1353672T3 (da) | Syntese af 4-amino-thalidomidenantiomerer | |
| IS2293B (is) | Arýl sambrædd asapólýsýklísk efnasambönd | |
| SE9900100D0 (sv) | New compounds | |
| MY136270A (en) | Processes and intermediates for preparing anti-cancer compounds | |
| CY1107475T1 (el) | Αναστολεις ρο-κινασης | |
| IS2564B (is) | Heterófjölhringjaefnasambönd og notkun þeirra sem metabótrópísk mótlyf gegn glútamat viðtökum | |
| DE60027913D1 (de) | 5-beta-sapogenin und pseudosapogeninderivate und ihre verwendung zur behandlung von demenz | |
| EA200500174A1 (ru) | Новые производные бензимидазола, полезные в качестве антипролиферативных агентов | |
| EA200300807A1 (ru) | Лечение нарушений центральной нервной системы с использованием антагонистов оксидазы d-аминокислот и d-аспартатоксидазы | |
| DK0556329T3 (da) | Substituerede piperaziner som midler til behandling af centralnervesystemet | |
| BRPI0409376A (pt) | derivados de indeno como agentes farmacêuticos | |
| WO2003057213A3 (en) | Cyclohexano- and cycloheptapyrazole derivative compounds, for use in diseases associated with the 5-ht2c receptor | |
| ATE255094T1 (de) | Piperazinderivate zur behandlung der niedrigen harnwege | |
| DE69917005D1 (de) | Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung | |
| ATE256126T1 (de) | 5-heteroatom-alkyl substituierte 3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid derivate zur behandlung zentral nervöser system störungen | |
| ATE297926T1 (de) | Hexahydropyrazino(1'2':1,6)-pyrido(3,4-b)indole 1,4-dion-derivate zur behandlung von cardiovaskulären erkrankungen und erektionsstörungen | |
| TWI245756B (en) | Improved process for the preparation of 1,3-substituted indenes | |
| DE69827706D1 (de) | 5-(Heteroaryl)alkyl)-3-oxo-pyrido(1,2-a)benzimidazol-4-carboxamid (PBI) Derivate zur Behandlung von Störungen des zentralen Nervensystems | |
| DE602004010186D1 (de) | Diazaspiropiperidinderivate als inhibitoren von glycintransporter 1 und glycintransporter 2 | |
| ATE289510T1 (de) | Sulfonylpyridazinone derivate zur behandlung von ischämischem gewebeschaden | |
| MY141048A (en) | Morpholine derivatives as norepinephrine reuptake inhibitors | |
| NO20012538L (no) | Anvendelse av N-substituerte azabicycloalkanderivater for behandling av forstyrrelser i sentralnervesystemet | |
| DE60215947D1 (de) | Pyridin-2-yl-methylamin-derivate zur behandlung von opiatsucht |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1224206 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |